Abstract
Alternating hemiplegia of childhood (AHC) is a rare neurodevelopmental disease caused by heterozygous de novo missense mutations in the ATP1A3 gene that encodes the neuronal specific α3 subunit of the Na,K-ATPase (NKA) pump. Mechanisms underlying patient episodes including environmental triggers remain poorly understood, and there are no empirically proven treatments for AHC. In this study, we generated patient-specific induced pluripotent stem cells (iPSCs) and isogenic controls for the E815K ATP1A3 mutation that causes the most phenotypically severe form of AHC. Using an in vitro iPSC-derived cortical neuron disease model, we found elevated levels of ATP1A3 mRNA in AHC lines compared to controls, without significant perturbations in protein expression. Microelectrode array analyses demonstrated that in cortical neuronal cultures, ATP1A3+/E815K iPSC-derived neurons displayed less overall activity than neurons differentiated from isogenic mutation-corrected and unrelated control cell lines. However, induction of cellular stress by elevated temperature revealed a hyperactivity phenotype following heat stress in ATP1A3+/E815K neurons compared to control lines. Treatment with flunarizine, a drug commonly used to prevent AHC episodes, did not impact this stress-triggered phenotype. These findings support the use of iPSC-derived neuronal cultures for studying complex neurodevelopmental conditions such as AHC and provide a platform for mechanistic discovery in a human disease model.
Original language | English (US) |
---|---|
Article number | 104881 |
Journal | Neurobiology of Disease |
Volume | 141 |
DOIs | |
State | Published - Jul 2020 |
Funding
This research was supported by funding from the Alternating Hemiplegia of Childhood Foundation (K.C.E. and A.L.G.). Additional funding was also provided by Association Française de l'Hémiplégie Alternante . J.P.S. was supported by NIGMS of the National Institutes of Health under award number T32GM007347 . We appreciate the helpful comments on this manuscript from members of the Ess laboratory, the assistance of Kevin Lazenby in processing MEA data, confocal microscopy assistance from Mary Chalkley, immunostaining assistance from Brittany P. Short, qPCR data collection guidance by Sam Palmer, and sample processing by the Vanderbilt VANTAGE Core.
Keywords
- ATP1A3
- Disease modeling
- Flunarizine
- Induced pluripotent stem cells
- Neurodevelopment
- Neuronal differentiation
ASJC Scopus subject areas
- Neurology